Dr. Christopher Robert Adam, MD

Dr. Adam practices at Ophthalmic Consultants of Long Island in East Setauket, New York.

Dr. Adam's NPI, 1962821355, was assigned on April 14, 2014. Dr. Adam graduated from State University of New York Downstate Medical Center College of Medicine in 2014. Dr. Adam holds Michigan license 4301114215.

Dr. Adam's primary practice is Ophthalmic Consultants of Long Island, at 4 Technology Dr, East Setauket, NY 11733 in Suffolk County. The practice phone is (631) 941-1400.

Dr. Adam's primary practice is Ophthalmic Consultants of Long Island in East Setauket, New York. Dmand AI also links Dr. Adam to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adam practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Adam's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Adam is licensed in Michigan.

CMS data shows 40,735 Medicare services from Dr. Adam across 20 procedure codes in 2024, for 1,632 Medicare patients. Medicare paid $3,402,330 for them.

CMS counts 1,632 Medicare patients who saw Dr. Adam in 2024. The largest group is 75 to 84, with 691 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Adam's median patient age at 71, with 56% women.

In 2024, Dr. Adam wrote 549 Medicare Part D claims for 170 patients. 40% of them were for generic drugs. CMS names the drug for 463 of them, across 12 drugs with 11 or more claims each, at $44,607 in total drug cost. In 2023, CMS named 238 claims across 6 drugs.

Dr. Adam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Adam, published from 2012 to 2023. The most frequent topics are Tomography, Optical Coherence, Endophthalmitis and Fluorescein Angiography. Dr. Adam has published most often in J Ophthalmol. Dr. Adam's most frequent co-authors are Gary Wayne Abrams, MD, Xihui Lin, MD and Alejandro Berenstein, MD.

CMS Open Payments shows 230 general payments to Dr. Adam from 29 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 87% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $1,358.

Dr. Adam graduated from State University of New York Downstate Medical Center College of Medicine in 2014.